⌕
Caris Life Sciences · CAI · Nasdaq
Tenet 40 · Weak
Compare
$21.00−8.85%At closeTenet 40 · Weak
$21.00−2.04 (−8.85%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Caris Life Sciences (CAI) Institutional Ownership

13F filers reported holding 54.1% of Caris Life Sciences (CAI) shares as of Jun 30, 2026, across 249 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
54.1%
Jun 30, 2026
13F filers
249
quarter ended Jun 30, 2026
13F value
$2.8B
155.2M shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 249 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 22, 2026Denton John RusselSee RemarksDisposed · Open-market sale7,500$31.82↗
Sep 17, 2026Brille Brian JSee RemarksAcquired · Option exercise400,000$2.44↗
Sep 17, 2026Brille Brian JSee RemarksDisposed · Open-market sale400,000$30.33↗
Sep 17, 2026Brille Brian JSee RemarksDisposed · Option exercise400,000Stock Option—↗
Sep 4, 2026Spetzler David BaxleyPresidentAcquired · Option exercise250,000$2.44↗
Sep 4, 2026Spetzler David BaxleyPresidentDisposed · Open-market sale119,212$24.76↗
Sep 4, 2026Spetzler David BaxleyPresidentDisposed · Option exercise250,000Stock Option—↗
Sep 3, 2026Spetzler David BaxleyPresidentAcquired · Option exercise1,000,000$2.44↗
Sep 3, 2026Spetzler David BaxleyPresidentDisposed · Open-market sale393,100$24.76↗
Sep 3, 2026Spetzler David BaxleyPresidentDisposed · Open-market sale84,900$25.32↗
Sep 3, 2026Spetzler David BaxleyPresidentDisposed · Option exercise1,000,000Stock Option—↗
Aug 14, 2026Fredrickson David PauldirectorAcquired · Grant / award13,192—↗
Aug 14, 2026Minor LloyddirectorAcquired · Grant / award13,192—↗
Aug 14, 2026Vacirca Jeff LdirectorAcquired · Grant / award13,192—↗
Aug 14, 2026Gilliam Joseph EdirectorAcquired · Grant / award13,192—↗
Aug 14, 2026PHILLIPS T DANNYdirectorAcquired · Grant / award13,192—↗
Aug 14, 2026CASTLEMAN PETER MdirectorAcquired · Grant / award13,192—↗
Aug 14, 2026JOHANSEN LAURA IdirectorAcquired · Grant / award13,192—↗
Aug 14, 2026HALBERT JONdirectorAcquired · Grant / award13,192—↗
May 29, 2026Knowles Jonathan Kenneth CharlesdirectorAcquired · Grant / award1,600$15.62↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Caris Life Sciences do institutions hold?

13F filers reported holding 54.1% of Caris Life Sciences' shares as of Jun 30, 2026, across 249 filers.

How many 13F filers hold Caris Life Sciences?

Caris Life Sciences was held by 249 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.